Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?Zacks Investment Research • 08/04/25
Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challengesWSJ • 08/01/25
Gear Up for Amgen (AMGN) Q2 Earnings: Wall Street Estimates for Key MetricsZacks Investment Research • 07/31/25
Amgen Gears Up to Report Q2 Earnings: Will the Beat Streak Continue?Zacks Investment Research • 07/30/25
NodThera Announces Appointment of Dr. Jyothis George as Chief Medical OfficerGlobeNewsWire • 07/21/25
Amgen (AMGN) Declines More Than Market: Some Information for InvestorsZacks Investment Research • 07/18/25
Undercovered Dozen: Christian Dior, Coca-Cola, Trinity Capital, Amgen And MoreSeeking Alpha • 07/18/25
Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff ConcernsSeeking Alpha • 07/16/25
Amgen (AMGN) Falls More Steeply Than Broader Market: What Investors Need to KnowZacks Investment Research • 07/11/25